Advances in Anticancer Drug Toxicology

Anticancer drugs, while targeting cancer cells, can cause significant toxicity to healthy tissues. Understanding the toxicological profiles of these drugs is critical for balancing efficacy and safety. Advances in personalized medicine, pharmacogenomics, and targeted therapies are reducing toxic side effects. Research into minimizing cardiotoxicity, hepatotoxicity, and neurotoxicity is improving the tolerability of anticancer treatments. Novel drug delivery systems, such as nanoparticles, are also helping to reduce off-target effects.

    Related Conference of Advances in Anticancer Drug Toxicology

    November 20-21, 2024

    13th International Conference on Climate Change & Environmental Science

    Rome, Italy
    November 28-29, 2024

    19th World Convention on Waste Recycling and Reuse

    Paris, France
    December 18-19, 2024

    3rd International Conference and Expo on Medical Toxicology and Applied Pharmacology

    Zurich, Switzerland
    February 13-14, 2025

    4th World Congress on Endocrinology & Diabetes

    Rome, Italy
    February 24-25, 2025

    4th World Congress on Sustainable Waste Management

    Madrid, Spain
    March 10-11, 2025

    12th International Conference on Pollution Control & Sustainable Environment

    Rome, Italy
    April 14-15, 2025

    13th World Conference on Climate Change

    Aix-en-Provence, France
    April 14-15, 2025

    6th Global Summit on Environmental Health

    Amsterdam, Netherlands
    April 14-15, 2025

    4th World Congress on Climate change and Ecosystem

    Madrid, Spain
    June 16-17, 2025

    20th World Bioenergy Congress and Expo

    Frankfurt, Germany
    August 26-27, 2025

    13th International Conference on Green Energy

    Paris, France

    Advances in Anticancer Drug Toxicology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in